免疫检查点诱导的结肠炎:一个单一中心的回顾性队列研究
Bengt Van Holder1,2, Julie Vereecke2,3, Nathan Ureel2
1Department of Medical Oncology, Ghent University Hospital, 9000 Ghent, Belgium.
Journal of clinical medicine
|October 29, 2025
概括
免疫检查点抑制剂 (ICI) 大肠炎通常是显微的,即使使用正常内镜. 联合ICI疗法预测类固醇耐药性,这表明早期的生物治疗是有效管理ICI诱导性结肠炎的必要.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 彻底改变了癌症治疗,但可以导致与免疫相关的不良事件,特别是结肠炎.
- 由于这些疗法的使用日益增加,了解和管理ICI诱导性结肠炎至关重要.
研究的目的:
- 详细介绍ICI诱导性大肠炎的临床,内镜和组织学特征.
- 评估ICI诱导大肠炎的治疗结果,在现实环境中使用皮质类固醇和生物制剂.
主要方法:
- 一项对77名ICI诱导大肠炎的成年患者进行的回顾性队列研究 (2012-2023年).
- 对临床,生化,内镜,组织学数据和治疗反应/安全结果的分析.
主要成果:
- 微观性结肠炎在88%的患者中发现,内镜检测结果正常.
- 联合ICI治疗与更高的梅奥得分和更大的生物制剂需求相关 (p=0.011).
- 皮质类固醇的临床响应率为79.6%,生物制剂的临床响应率为100%;ICI重新挑战的复发率为17.4%.
结论:
- 随机活检的微观发现在ICI诱导的大肠炎中很常见,即使没有内镜迹象.
- 联合ICI疗法可能表明,由于皮质类固醇耐药性,需要早期升级至生物药物.
- 在可管理的大肠炎发病率的情况下,ICI重新挑战是可行的,尽管需要进行前性研究.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
3.1K
08:37Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
17.4K
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
480
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480
Inflammatory Bowel Disease I: Ulcerative Colitis
882
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
